NCT04609332View on ClinicalTrials.gov

Endothelial Damage and Angiogenesis Biomarkers During COVID-19

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 10, 2020

Primary Completion Date

September 26, 2021

Study Completion Date

November 30, 2021

Conditions
Covid19AngiogenesisEndothelial DysfunctionCardiovascular Morbidity
Interventions
DIAGNOSTIC_TEST

Endothelial damage and angiogenic biomarkers

Blood samples for biomarkers study

Trial Locations (1)

8380456

Hospital Clínico de la Universidad de Chile, Independencia

All Listed Sponsors
lead

University of Chile

OTHER

NCT04609332 - Endothelial Damage and Angiogenesis Biomarkers During COVID-19 | Biotech Hunter | Biotech Hunter